TickerFacts.

BillionToOne, Inc. (BLLN): Shareholders' Equity

Annual figures by period end, from SEC filings.

$480.11M
As of 2025-12-31
$536.81M
As of 2026-06-30
2023-12-31: -$219.05M2024-12-31: -$251.66M2025-12-31: $480.11M$480.11M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$480.11Mn/m2026-03-11, Balance as of period end
2024-12-31-$251.66Mn/m2026-03-11, Balance as of period end
2023-12-31-$219.05Mn/a2026-03-11, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
BillionToOne, Inc. (BLLN)2025-12-31$480.11Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31$1.11B-1.9%
Castle Biosciences Inc (CSTL)2025-12-31$470.87M+3.3%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
GRAIL, Inc. (GRAL)2025-12-31$2.58B+3.0%
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m

Compare BLLN, FLGT, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗